Sunday, November 24, 2024
Home Oncology & Cancer
Category:

Oncology & Cancer

banner
by Medical Xpress

Histological analysis of infiltrating immune cells reveals downregulated innate immune response in JunPEΔ/Δ; PtenPEΔ/Δ prostates. …

by Medical Xpress

Credit: CC0 Public Domain According to preliminary data from a multi-institution Phase III trial led …

by Medical Xpress

Development of a CTR by SuFEx engineering and successful proof of concept in tumor-bearing mice. …

by Medical Xpress

Credit: Unsplash/CC0 Public Domain Researchers at Karolinska Institutet in Sweden and the University of Innsbruck …

by Medical Xpress

Progression-free survival by investigator assessment in the intention-to-treat population. HR, hazard ratio; NR, not reached. …

by Medical Xpress

synDNA-delivered PMTE demonstrates better durability and tumor control in vivo. Credit: O’Connell et al. (2024) …

by Medical Xpress

Immunotherapy is based on harnessing a person’s own immune system to attack cancer cells. However, …

by Medical Xpress

Credit: Unsplash/CC0 Public Domain A medication to treat chronic myeloid leukemia (CML) has shown its …

by Medical Xpress

Credit: Pixabay/CC0 Public Domain NRG Oncology recently reported the results from the radiotherapy randomization, which …

by Medical Xpress

Credit: Journal of Nuclear Medicine (2024). DOI: 10.2967/jnumed.123.267321 Extended prostate-specific membrane antigen (PSMA)-targeted radiopharmaceutical therapy …

by Medical Xpress

Characterization of BKCa channels in murine and human BCCs. Credit: eLife (2024). DOI: 10.7554/eLife.92511.3 Researchers …

by Medical Xpress

Credit: Anna Tarazevich from Pexels For the last three decades, breakthroughs have been sparse for …

Edtior's Picks

Latest Articles

All Rights reserved, site designed by Yellohost.co.za